0001683168-22-006803 Sample Contracts

SEPARATION, CONSULTING AND RELEASE AGREEMENT

Separation, Consulting and Release Agreement • October 7th, 2022 • PharmaCyte Biotech, Inc. • Biological products, (no disgnostic substances) • Nevada

• Contract Type
  Separation, Consulting and Release Agreement
• Filed
  October 7th, 2022
• Company
  PharmaCyte Biotech, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Nevada

This Separation, Consulting and Release Agreement (this “Agreement”), delivered October 4, 2022, confirms the following understandings and agreements between PharmaCyte Biotech, Inc. (“Company”) and Kenneth L. Waggoner (“you” or “your”).